ACELYRIN, INC. to Host Virtual Investor Event to Share new Phase 2 Data and Phase 3 Program Design for Subcutaneous Lonigutamab
January 02, 2025 20:00 ET | Source: ACELYRIN, INC. LOS ANGELES, Jan.…
January 02, 2025 20:00 ET | Source: ACELYRIN, INC. LOS ANGELES, Jan.…
Sign in to your account